NasdaqGS:MRNABiotechs
Moderna (NasdaqGS:MRNA) Joins Russell Midcap Indices In Late June 2025
In late June 2025, Moderna (NasdaqGS:MRNA) underwent significant index changes, adding to the Russell Midcap indices while exiting the Russell Top 200 indices. This reclassification might have signaled a shift in investor perception, aligning with the company's 18% share price increase over the last quarter. Despite the broader market experiencing a rally with indexes like the S&P 500 and Nasdaq reaching record highs, Moderna's earnings report, strategic alliances, and product-related updates...